Trends in the prostate cancer incidence in India

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 1, 2008, Pages 141-144

  Yeole, Balkrishna ^a  

^a Bombay Cancer Registry   (India)

Author keywords

Incidence; Prostate cancer; Trends

Indexed keywords

EID: 58349092839     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Black RJ, Sharp L, Kendric SW (1993). Trends in Cancer Survival in Scotland 1968-90. Information and Statistics Division, Edinburgh.
2. Cancer Incidence in Five Continents, Vol VIII, International Agency of Research on Cancer, Scientific Publication No. 1555, (Eds): Parkin DM, Whelan SL, Ferlay J, Teppo L, and Thomas DB, 2002.
3. Cancer Incidence in Five Continents (1982). Vol. IV, IARC Scientific Publication No. 42, Edited by J Waterhouse, C Muir, K shanmugaratnam, J Powell, IARC, Lyon, France.
4. Cancer Incidence & Mortality in Greater Mumbai-2001, Indian Cancer Society, 2005.
5. Cancer Incidence in Five Continents (1992). Vol. VI, IARC Scientific Publication No. 120, Edited by: DM Parkin, CS Muir, SL Whelan, YT Gao, J Ferlay and J Powell. IARC Lyon, France.
6. Cancer Incidence in Five Continents (1997). Vol. VII, IARC Scientific Publication No.143, Edited by, DM Parkin, SL Whelan, J Ferlay, A Raymond and J Young. IARC, Lyon, France.
7. Carr TW (1993). Natural history of prostate cancer, Lancer, 341, 91-2.
8. Cayuela A, Lacalle JR, Gili M (1989). Analysis of cohort mortality from prostatic cancer in Spain, 1951-1983, J Epidemiol Community Health, 43, 249-52.
9. Chamberlain J, Melia J, Moss S, et al (1997). The diagnosis, management, treatment and costs of prostate cancer in England and Wales, Health Technol Assess, 1, 1-53.
10. Ferlay J, Bray F, Pisani P, et al (2004). GLOBOCAN 2002, Cancer Incidence, Mortality Worldwide. Version 2.0. International Agency for Research on Cancer, Lyon, France.
11. Ferlay J, Bray F, Sankila R, et al (1999). EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1996, Version 3.1, IARC Cancer Base No.4, IARC Press, Lyon.
12. Grosclaude P, Menegoz F, Schaffer P (1997) Prostate Cancer screening (II): Is Prostate Cancer a Public Health problem? Update of incidence and mortality figures in France from 1982 to 1990. Prog Urol, 7, 647-54.
13. Hankey BF, Feuer EJ, Clegg LX (1999). Cancer Surveillance Series: Interpreting trends in prostate cancer part I: evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst, 91, 1017-24.
14. Hsing AW, Tsao L, Devesa SS (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer, 85, 60-7.
15. Jemal A, Tiwari RC, Murray T (2004). Cancer statistics, 2004, CA Cancer J Clin, 54, 8-29.
16. National Cancer Registry Programme (2006). Consolidated Programme of Cancer Registries, 2001-2004, Indian Council of Medical Research, New Delhi.
17. Mc Laughlin JR, Kreiger N, Marrett LD, et al (1991). Cancer incidence registration and trends in Ontairo. Eur J Cancer, 27, 1520-4.
18. Mercer SL, Goel V, Levy IG, et al (1997). Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions. Can J Public Health, 88, 327-32.
19. Michel PC, Jacques E, Philippe D, et al (1993). Trends in Cancer Incidence and Mortality, IARC Scientific Publication No.121, International Agency for Research on Cancer, Lyon, 499-520.
20. Møller B, Fejaer H, Hakulinen T, et al (2002). Prediction of cancer incidence in the Nordic Countries up to the year 2020. Eur J Cancer Prev, 11(Suppl 1), 2751-66.
21. Muir CS, Malhotra A (1987). Changing patterns of cancer incidence in five continents. Gann Monogr Cancer Res, 33, 3-23.
22. Parkin DM, Vatanasapt V (2001). Cancer Registration in Asia in the year 2000. Past, Present and Future, Asian Pacific J Cancer Prevention, 5, 1-89.
23. Ponten J, Adami HO, Sparen P (1991). Trends in cancer survival and mortality rates. Med Oncol Tumor Pharmacother, 8, 147-53.
24. Post PN, Kil PJ, Crommelin MA, et al (1998). Trends in Incidence and Mortality rates for prostate cancer before and after prostate-specific antigen introduction. A Registry-based study in Southeastern Netherlands 1971-1995. Eur J Cancer, 34, 705-9.
25. Potosky AL, Kessler L, Gridley G, et al (1990). Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst, 82, 1624-8.
26. Ries L, Esner M, Kosary CL, et al (1999). SEER Cancer Statistics Review, 1973-96, National Cancer Institute, Bethesda, MD.
27. Ries L, Kosary CL, Hankey BA, et al (2000). SEER Cancer Statistics Reivew, 1973-97, Natl Cancer Inst, Bethesda, MD.
28. Severson RK (???). Has transurethral resection contributed to the increasing incidence of prostatic cancer? J Natl Cancer Inst, 82, 1597-8.
29. Sim HG, Chang CW (2005). Changing demography of prostate cancer in Asia. Eur J Cancer, 41, 834-45.
30. Threlfall TH, English DR, Rouse IL (1998). Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996. Med J, 169, 21-4.
31. World Health Organization (2000). International Classification of Disease for Oncology, Third Edition, Geneva: WHO.
32. World Health Organization Manual of the International Classification of Diseases, Injuries, cause of death (ICD-10) Vol.1, Geneva: WHO, 1992.
33. Yatani R, Shiraishi T, Takakuku K, et al (1988). Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst, 80, 683-7.